Competitive analysis in Nervous System Drugs industry

Top companies filing patent oppositions

Total Oppositions
23
Company
Total Oppositions
19
Total Oppositions
16
Company
Total Oppositions
15
Total Oppositions
13
Total Oppositions
10
Total Oppositions
9
Total Oppositions
9
Total Oppositions
9

Top companies facing patent oppositions

Total Oppositions
38
Total Oppositions
30
Total Oppositions
23
Total Oppositions
20
Total Oppositions
20
Total Oppositions
20
Total Oppositions
20
Total Oppositions
16
Total Oppositions
16
Total Oppositions
16

Latest patents granted in the Nervous System Drugs industry

Patent:
Grant Date:
Aug 21, 2024
Title:
Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine
Applicant:
Patent:
Grant Date:
Jul 17, 2024
Title:
Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Patent:
Grant Date:
Mar 20, 2024
Title:
Methods For Treating Huntington'S Disease
Patent:
Grant Date:
Mar 20, 2024
Title:
5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Depression
Patent:
Grant Date:
Jan 24, 2024
Title:
Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The Same
Patent:
Grant Date:
Dec 20, 2023
Title:
Extended Release Suspension Compositions
Patent:
Grant Date:
Dec 6, 2023
Title:
Methods Of Treating Ocular Conditions
Patent:
Grant Date:
Nov 15, 2023
Title:
Fc Riib-Specific Fc Antibody
Patent:
Grant Date:
Oct 4, 2023
Title:
Method For Controlling Neuroinflammation
Applicant:
Patent:
Grant Date:
Sep 13, 2023
Title:
Musk Composition And Methods Of Use Thereof

Top patents facing oppositions in Nervous System Drugs industry

Patent
Grant Date
Jul 15, 2020
Title
Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor
Oppositions
48
Patent
Grant Date
Mar 31, 2021
Title
Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters
Oppositions
40
Patent
Grant Date
Apr 22, 2020
Title
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters
Oppositions
32
Patent
Grant Date
Dec 21, 2022
Title
Stable Cannabinoid Formulations
Oppositions
30
Patent
Grant Date
May 11, 2022
Title
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring
Oppositions
25
Patent
Grant Date
May 1, 2013
Title
Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine
Oppositions
24
Patent
Grant Date
Jun 7, 2023
Title
Methylene Blue And Its Medical Use
Oppositions
24
Patent
Grant Date
Nov 9, 2022
Title
Formulations Of (R
Oppositions
18
Patent
Grant Date
Nov 21, 2018
Title
Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related Disorders
Applicant
Oppositions
18
Patent
Grant Date
Nov 2, 2022
Title
Nutritional Product
Oppositions
12

Need more information?

Feel free to send us a message here and we will get back to you